Stress Disorders, Post-Traumatic Clinical Trial
Official title:
Feasibility of a Yoga Program for Veterans With PTSD
NCT number | NCT05177757 |
Other study ID # | HR- 3973 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 3, 2022 |
Est. completion date | May 28, 2022 |
Verified date | September 2022 |
Source | Marquette University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is designed to examine the feasibility of a 12-week yoga program on physiological and psychological health and its neurobiological mechanisms in N=15 veterans with posttraumatic stress disorder (PTSD). The investigators will be examining specific parameters of health and mechanisms before and after the yoga program.
Status | Completed |
Enrollment | 14 |
Est. completion date | May 28, 2022 |
Est. primary completion date | May 27, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - U.S. Military Veteran - 18 years of age or older - Diagnosis of PTSD as assessed by a score of >30 on the PTSD-Checklist Version 5 (PCL-5) - Willing and able to attend testing and yoga sessions at the Athletic and Human Research Performance Center (AHPRC) on the campus of Marquette University - Clear to participate in physical activity based on the Physical Activity Readiness Questionnaire (PARQ+) Exclusion Criteria: - Currently pregnant or trying to become pregnant - Positive score to one or more items on the PAR-Q+ without physician approval - Already established regular use of yoga (i.e., more than one day per week) |
Country | Name | City | State |
---|---|---|---|
United States | Marquette University | Milwaukee | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
Marquette University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Endocannabinoid assay | Endocannabinoid ligands reported in ng/ml | Change in ligands from baseline to12 weeks | |
Primary | Cortisol assay | Cortisol reported in µg/dL | Change in cortisol from baseline to12 weeks | |
Primary | Cognitive functioning using a computerized battery | Performance on cognitive tasks reported in accuracy and reaction time | Change in performance from baseline to12 weeks | |
Primary | Body Mass Index (BMI) | Body Mass Index (BMI) calculated by height and weight | Change in BMI from baseline to12 weeks | |
Primary | Blood pressure | Blood pressure reported in systolic and diastolic (mmHg) | Change in blood pressure from baseline to12 weeks | |
Primary | Heart rate | Heart rate reported in beats per minute (BPM) | Change in heart rate from baseline to12 weeks | |
Primary | Heart rate variability (HRV) | Heart rate variability (HRV) reported in the standard deviation of the RR intervals (distance between heartbeats) as quantified on standard electrocardiogram (ECG) | Change in HRV from baseline to12 weeks | |
Primary | Lung functioning | Lung functioning measured by spirometry reported in vital capacity (VC) | Change in lung functioning from baseline to12 weeks | |
Primary | Range of motion | Range of motion measured by goniometer reported in degrees | Change in range of motion from baseline to12 weeks | |
Primary | Body composition | Body composition measured by dual-energy x-ray absorptiometry (DEXA) reported in volume cubic meters (m3) and mass (kilograms) | Change in body composition from baseline to12 weeks | |
Primary | Hand grip strength | Hand grip strength measured by a dynamometer reported in pounds (lbs) | Change in hand grip strength from baseline to12 weeks | |
Primary | Aerobic fitness | Aerobic fitness measured by a submaximal graded exercise test reported in the volume of oxygen consumed (VO2) | Change in aerobic fitness from baseline to12 weeks | |
Primary | Physical activity | Physical activity measured by a accelerometer reported in change in velocity over time (meters per seconds) | Change in physical activity from baseline to12 weeks | |
Primary | Severity of posttraumatic stress disorder (PTSD) | Scores on the Clinician Administered PTSD Scale (CAPS-5) (range 0-80; higher scores indicate more severity) | Change in scores from baseline to12 weeks | |
Primary | Frequency of physical activity | Scores on the International Physical Activity Questionnaire-Short Form (IPAQ-SF) reported in hours and minutes each day | Change in scores from baseline to12 weeks | |
Primary | Physical health rating | Scores on the Medical Outcomes Study-Short Form (SF-36) (range 0-100; higher scores indicate better health outcome) | Change in scores from baseline to12 weeks | |
Primary | Severity of sleep disturbance | Scores on the Pittsburgh Sleep Quality Index (PSQI) (range 0-21; higher scores indicate worse sleep quality) | Change in scores from baseline to12 weeks | |
Primary | Mindfulness rating | Scores on the Five Facet Mindfulness Questionnaire (FFMQ) (range 39-195; higher scores indicate more mindfulness) | Change in scores from baseline to12 weeks | |
Primary | Frequency of yoga rating | Scores on the Yoga and Self-efficacy Scale (YSES) (range 12-108; higher scores indicate more engagement with yoga practices) | Change in scores from baseline to12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05620381 -
Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018
|
||
Completed |
NCT02856412 -
Improving Mind/Body Health and Functioning With Integrative Exercise
|
N/A | |
Recruiting |
NCT05400200 -
PTSD and Self-regulation: Coping, Emotional Regulation and Cognitive Control and Their Relationships to Symptom Management
|
N/A | |
Not yet recruiting |
NCT06088303 -
Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication
|
N/A | |
Not yet recruiting |
NCT03652922 -
Propranolol Reactivation Mismatch (PRM) Treatment for PTSD
|
Phase 4 | |
Completed |
NCT02875912 -
Prospective Evaluation of Family Care Rituals in the ICU
|
N/A | |
Completed |
NCT01589575 -
Anxiety and Depression in Relatives of Critically Ill Patients: Spouses Versus Other Close Relatives
|
N/A | |
Completed |
NCT00990106 -
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT01291368 -
Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care
|
N/A | |
Active, not recruiting |
NCT00657787 -
Development of a Post-Traumatic Stress Disorder (PTSD) Population Registry for Veterans
|
||
Completed |
NCT00880152 -
Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study
|
N/A | |
Completed |
NCT01365247 -
Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00835627 -
Treatment Trial for Psychogenic Nonepileptic Seizures
|
Phase 4 | |
Completed |
NCT00419029 -
Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment
|
N/A | |
Completed |
NCT00514956 -
Effect of Emotional Freedom Technique and Diaphragmatic Breathing on Post Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT00333710 -
Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD
|
N/A | |
Completed |
NCT01120847 -
Post Traumatic Stress Disorder (PTSD), Sleep Disordered Breathing And Genetics: Effects On Cognition
|
||
Completed |
NCT00069225 -
Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder
|
N/A | |
Completed |
NCT00055354 -
Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00186212 -
Alternative Support for Rural and Isolated Women in an HMO
|
Phase 3 |